Forza X1, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000173112224000813 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.189M	$9.953M	$10.68M
YoY Change	-50.42%	-6.84%	1571.62%
Cash & Equivalents	$8.189M	$9.953M	$10.68M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$73.51K	$129.5K	$496.3K
YoY Change	-53.71%	-73.9%	2396.73%
Inventory	$273.1K	$403.6K	$42.83K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$8.554M	$10.49M	$11.22M
YoY Change	-50.26%	-6.56%	1603.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.565M	$4.984M	$1.022M
YoY Change	357.43%	387.85%	281.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.520K	$7.520K	$7.520K
YoY Change	0.0%	0.0%
Other Assets
YoY Change
Total Long-Term Assets	$4.603M	$5.045M	$1.170M
YoY Change	309.32%	331.22%	138.94%
TOTAL ASSETS
Total Short-Term Assets	$8.554M	$10.49M	$11.22M
Total Long-Term Assets	$4.603M	$5.045M	$1.170M
Total Assets	$13.16M	$15.53M	$12.39M
YoY Change	-28.19%	25.33%	978.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$503.6K	$34.27K	$49.56K
YoY Change	536.58%	-30.84%	34.0%
Accrued Expenses	$27.81K	$72.78K	$77.17K
YoY Change	-75.06%	-5.69%	222.88%
Deferred Revenue	$6.175K	$5.700K	$5.800K
YoY Change	6.47%	-1.72%
Short-Term Debt	$0.00	$122.3K	$0.00
YoY Change	-100.0%		-100.0%
Long-Term Debt Due	$24.54K	$25.23K	$16.83K
YoY Change	44.18%	49.91%
Total Short-Term Liabilities	$585.2K	$306.2K	$237.1K
YoY Change	43.84%	29.13%	96.98%
LONG-TERM LIABILITIES
Long-Term Debt	$73.40K	$78.46K	$72.74K
YoY Change	8.39%	7.86%
Other Long-Term Liabilities			$45.92K
YoY Change
Total Long-Term Liabilities	$73.40K	$78.46K	$118.7K
YoY Change	-19.15%	-33.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$585.2K	$306.2K	$237.1K
Total Long-Term Liabilities	$73.40K	$78.46K	$118.7K
Total Liabilities	$658.6K	$384.7K	$355.8K
YoY Change	32.35%	8.12%	195.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.02M	-$11.19M	-$6.093M
YoY Change	85.05%	83.64%
Common Stock	$15.78K	$15.78K	$10.45K
YoY Change	0.0%	51.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$21.38K	$21.38K
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.50M	$15.15M	$12.04M
YoY Change
Total Liabilities & Shareholders Equity	$13.16M	$15.53M	$12.39M
YoY Change	-28.19%	25.33%	978.93%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001901305
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41469
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	FORZA X1, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3159685
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3101 S. US-1
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Pierce
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34982
CY2024Q1	dei	City Area Code CityAreaCode	772
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	429-2525
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	FRZA
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15762750	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9952749	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2981720	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	403625	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	493460	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	129544	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73508	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	10485918	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	13370219	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	52869	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75147	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4984208	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3468961	usd
CY2024Q1	us-gaap	Assets Assets	15530512	usd
CY2023Q4	us-gaap	Assets Assets	16921844	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	34274	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	86820	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	72778	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462381	usd
CY2024Q1	FRZA	Due To Affiliated Companies DueToAffiliatedCompanies	122322	usd
CY2023Q4	FRZA	Due To Affiliated Companies DueToAffiliatedCompanies	201848	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	25230	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17313	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	45916	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68532	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5700	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5700	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	306220	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	842594	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	78455	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	58717	usd
CY2024Q1	us-gaap	Liabilities Liabilities	384675	usd
CY2023Q4	us-gaap	Liabilities Liabilities	901311	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15784000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15784000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15754774	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15754774	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	15784	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15784	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	29226	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	29226	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	21379	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	21379	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26340014	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26046873	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11188582	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10020745	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	15145837	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16020533	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15530512	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16921844	usd
CY2024Q1	us-gaap	Revenues Revenues	0	usd
CY2023Q1	us-gaap	Revenues Revenues	0	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	29572	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	49941	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-29572	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-49941	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	277052	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	354662	usd
CY2024Q1	us-gaap	Salaries And Wages SalariesAndWages	690543	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	862764	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	169198	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	702648	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	93029	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	124040	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	55945	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	35696	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1285767	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2079810	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1315339	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2129751	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	3125	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	291	usd
CY2024Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	132347	usd
CY2023Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	124910	usd
CY2024Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-16930	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2024Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	35210	usd
CY2023Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	147502	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	124619	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-1167837	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-2005132	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1167837	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2005132	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15754774	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15754774	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10450000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10450000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	341163	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2005132	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12036234	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16020533	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	293141	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1167837	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	15145837	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1167837	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2005132	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	55945	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	35696	usd
CY2024Q1	FRZA	Change In Fair Value Of Marketable Securities Available For Sale ChangeInFairValueOfMarketableSecuritiesAvailableForSale	-16930	usd
CY2023Q1	FRZA	Change In Fair Value Of Marketable Securities Available For Sale ChangeInFairValueOfMarketableSecuritiesAvailableForSale	-0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	293141	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	341163	usd
CY2024Q1	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	-22278	usd
CY2023Q1	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	-21411	usd
CY2024Q1	FRZA	Change In Inventory Reserve ChangeInInventoryReserve	113252	usd
CY2023Q1	FRZA	Change In Inventory Reserve ChangeInInventoryReserve	0	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23417	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42829	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	56036	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-152752	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-52546	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-49473	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-389603	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15598	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-22616	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-21072	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	500	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1210509	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1582582	usd
CY2024Q1	FRZA	Net Redemptions Of Investment In Trading Marketable Securities NetRedemptionsOfInvestmentInTradingMarketableSecurities	3000000	usd
CY2023Q1	FRZA	Net Redemptions Of Investment In Trading Marketable Securities NetRedemptionsOfInvestmentInTradingMarketableSecurities	0	usd
CY2024Q1	FRZA	Realized Gain On Sale Of Marketable Securities RealizedGainOnSaleOfMarketableSecurities	35210	usd
CY2023Q1	FRZA	Realized Gain On Sale Of Marketable Securities RealizedGainOnSaleOfMarketableSecurities	-0	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1539620	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	199559	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1425170	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-199559	usd
CY2024Q1	FRZA	Repayments Of Finance Lease RepaymentsOfFinanceLease	3917	usd
CY2023Q1	FRZA	Repayments Of Finance Lease RepaymentsOfFinanceLease	2836	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	274728	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	409505	usd
CY2024Q1	FRZA	Advances From Affiliates AdvancesFromAffiliates	195202	usd
CY2023Q1	FRZA	Advances From Affiliates AdvancesFromAffiliates	110283	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-83443	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-302058	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	131218	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2084199	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9821531	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12767199	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9952749	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10683000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	3125	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	291	usd
CY2024Q1	FRZA	Right Of Use Asset Finance Leases RightOfUseAssetFinanceLeases	31572	usd
CY2023Q1	FRZA	Right Of Use Asset Finance Leases RightOfUseAssetFinanceLeases	92405	usd
CY2024Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	5700	usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	5700	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zPAm780btV7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: -0.5pt"><b><span id="xdx_86A_zVeP7DBn1gua">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: -0.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States “U.S. GAAP” requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about useful life of fixed assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"> </p>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9952749	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zHC6RvLVzskf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: -0.5pt"><b><span id="xdx_868_zyQZEPgy0G45">Concentrations of Credit and Business Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: -0.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_90B_ecustom--FdicInsuredLimit_iI_c20240331_zpfO1ihEkVi1" title="FDIC insured limit">250,000</span> are at risk. At March 31, 2024 and December 31, 2023, the Company had $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_c20240331_zqI0XWCEC5pl" title="FDIC excess amount">9,699,907</span> and $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zME60OkF8jm" title="FDIC excess amount">9,557,799</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"> </p>
CY2024Q1	FRZA	Fdic Insured Limit FdicInsuredLimit	250000	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	9699907	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	9557799	usd
CY2024Q1	us-gaap	Other Inventory OtherInventory	464410	usd
CY2023Q4	us-gaap	Other Inventory OtherInventory	351158	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9952749	usd
CY2024Q1	FRZA	Working Capital WorkingCapital	10179698	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
CY2023Q4	FRZA	Working Capital WorkingCapital	12527625	usd
CY2023Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	6929552	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1167837	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2005132	usd
CY2023Q4	FRZA	Marketable Securities Amortized Cost MarketableSecuritiesAmortizedCost	2930842	usd
CY2023Q4	FRZA	Marketable Securities Gross Unrealized Gains MarketableSecuritiesGrossUnrealizedGains	50878	usd
CY2023Q4	FRZA	Marketable Securities Gross Unrealized Losses MarketableSecuritiesGrossUnrealizedLosses	0	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	2981720	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	2981720	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5274565	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3703373	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	290357	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	234412	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	4984208	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3468961	usd
CY2024Q1	us-gaap	Depreciation Depreciation	55945	usd
CY2023Q1	us-gaap	Depreciation Depreciation	35696	usd
CY2022Q4	FRZA	Treasury Stock Acquired Average Cost Precentage TreasuryStockAcquiredAverageCostPrecentage	0.0033	pure
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	7715	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	52869	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75147	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	45916	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68532	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	45916	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	68532	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	46453	usd
CY2024Q1	FRZA	Lessee Operating Leases Liability Payments Due LesseeOperatingLeasesLiabilityPaymentsDue	46453	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	537	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	45916	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2024Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P0Y5M15D
CY2023Q1	FRZA	Net Asset Value NetAssetValue	48826	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.030	pure
CY2023Q1	FRZA	Net Asset Value NetAssetValue	43579	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2024Q1	FRZA	Net Asset Value NetAssetValue	33393	usd
CY2024Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	25230	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	78455	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	21698	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	28931	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	28931	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	28051	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	4655	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	112268	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	8582	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	103685	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	274728	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	409505	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	195202	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	110283	usd
CY2022Q3	us-gaap	Short Term Lease Payments ShortTermLeasePayments	2500	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	7500	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	7500	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	19590	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	59177	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	53188	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	403204	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	72778	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462381	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	172500	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.25
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	306705	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.88
CY2024Q1	FRZA	Warrant Activity WarrantActivity	0	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	293141	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	341163	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.08	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.13	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0298	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0472	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1441500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.41
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P0Y18D
CY2022Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	518000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.70
CY2023	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P9Y9M3D
CY2023	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted	287835	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	69583	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.24
CY2023	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P9Y7M13D
CY2023	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited	40248	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1889917	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.75
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y4M9D
CY2023Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4257500	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	396843	shares
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.66
CY2024Q1	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P8Y11M23D
CY2024Q1	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited	69413	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1493074	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.75
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y9M10D
CY2024Q1	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4188087	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	748750	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.48
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y6M29D
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001731122-24-000813-index-headers.html	Edgar Link	pending
0001731122-24-000813-index.html	Edgar Link	pending
0001731122-24-000813.txt	Edgar Link	pending
0001731122-24-000813-xbrl.zip	Edgar Link	pending
e5663_10-q.htm	Edgar Link	pending
e5663_ex31-1.htm	Edgar Link	pending
e5663_ex31-2.htm	Edgar Link	pending
e5663_ex32-1.htm	Edgar Link	pending
e5663_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
frza-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
frza-20240331_cal.xml	Edgar Link	unprocessable
frza-20240331_def.xml	Edgar Link	unprocessable
frza-20240331_lab.xml	Edgar Link	unprocessable
frza-20240331_pre.xml	Edgar Link	unprocessable
e5663_10-q_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Forza X1, Inc.

2024 Q2 Form 10-Q Financial Statement

#000173112224000813 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission